als 8123 has been researched along with sofosbuvir in 1 studies
| Studies (als 8123) | Trials (als 8123) | Recent Studies (post-2010) (als 8123) | Studies (sofosbuvir) | Trials (sofosbuvir) | Recent Studies (post-2010) (sofosbuvir) |
|---|---|---|---|---|---|
| 5 | 0 | 1 | 2,164 | 318 | 2,064 |
| Protein | Taxonomy | als 8123 (IC50) | sofosbuvir (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 8.4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amblard, F; Bassit, L; Cao, D; Downs-Bowen, J; Kim, B; Kleinbard, R; Liang, B; McBrayer, T; Musall, K; Oo, A; Russell, OO; Schinazi, RF; Zandi, K | 1 |
1 other study(ies) available for als 8123 and sofosbuvir
| Article | Year |
|---|---|
Repurposing Nucleoside Analogs for Human Coronaviruses.
Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Coronavirus OC43, Human; Drug Evaluation, Preclinical; Drug Repositioning; Humans; Nucleosides; Propanolamines; SARS-CoV-2; Sofosbuvir; Vero Cells | 2020 |